Entero Healthcare IPO Details | GMP, Date, Price, Review

Entero Healthcare IPO Details ( Entero Healthcare Solutions Limited IPO Review )

(9 Feb 2024 – 13 Feb 2024)

Established in 2018, Entero Healthcare Solutions Limited operates as a healthcare product distributor in India. Using advanced technology, the company delivers healthcare products to pharmacies, hospitals, and clinics across the country.

Throughout the fiscal years 2021, 2022, and 2023, Entero Healthcare Solutions catered to 39,500, 64,200, and 81,400 retail customers, respectively. In the same period, they also served 1,600, 2,500, and 3,400 hospital customers.

Entero Healthcare Solutions collaborates with more than 1,900 healthcare product manufacturers, granting them access to a diverse range of over 64,500 product variations as of March 31, 2023.

With 73 warehouses spread across 37 cities in 19 states and union territories, the company’s extensive reach encompasses 81,400 pharmacies and 3,400 hospitals in 495 districts as of March 31, 2023. This widespread network ensures efficient connections with healthcare product manufacturers.

As of March 31, 2023, Entero Healthcare Solutions employs a total of 3,014 individuals across various departments.

Entero Healthcare Solutions Limited IPO Competitive Strength

• We operate in the large and highly fragmented Indian healthcare products distribution market and expect to benefit from market consolidation
• We are one of India’s largest and fastest growing healthcare products distribution platforms
• Track record of inorganic expansion and integration to grow our geographic reach, revenues and scale
• Differentiated business model offering comprehensive and integrated commercial and supply chain solutions
• Proprietary technology platform with integrated business intelligence tools and solutions
• Experienced, committed and qualified founding and professional management team with deep industry expertise and backed by healthcare focused investor

Entero Healthcare IPO Financials Performance ( Results )

Entero Healthcare Solutions Limited Financial Information (Restated Consolidated)

All Amount in ₹ Lakhs

Period Ended	Total Assets	Total Revenue	PAT	EPS (₹)	Net Worth	Borrowing
31-Mar-21	833.79	1,783.67	-15.35	-5.29	487.06	141.70
31-Mar-22	1,125.98	2,526.55	-29.44	-9.22	563.22	285.03
31-Mar-23	1,308.73	3,305.72	-11.10	-3.10	597.66	373.52
30-Sep-23	1,505.95	1,898.98	11.64	2.95	660.54	488.68

Objective of Entero Healthcare IPO Issue

• Repayment/prepayment, in full or part, of certain borrowings availed of by the company and its Subsidiaries.
• Funding the long term working capital requirements.
• Pursuing inorganic growth initiatives through acquisitions.
• General corporate purposes.

Entero Healthcare IPO Basic Details

IPO Date	Feb 9, 2024 to Feb 13, 2024
Listing Date	Friday, February 16, 2024
Face Value	₹10 per share
Price	₹1195 to ₹1258 per share
Lot Size	11 Shares
Issue Size	12,718,600 shares of ₹10 (aggregating up to ₹1,600.00 Cr)
Fresh Issue	7,949,125 shares of ₹10 (aggregating up to ₹1,000.00 Cr)
Offer for Sale	4,769,475 shares of ₹10 (aggregating up to ₹600.00 Cr)
Employee Discount	Rs 119 per share
Issue Type	Book Built Issue IPO
Listing At	NSE, BSE
Share holding pre issue	39,577,705
Share holding post issue	47,526,830
Company Promoters	Prabhat Agrawal, Prem Sethi, and OrbiMed Asia III Mauritius Limited

Entero Healthcare Solutions IPO Reservation

Anchor Investor Shares Offered	42.63% of the Net Issue
QIB Shares Offered	28.42% of the Net Issue
NII (HNI) Shares Offered	14.21% of the Net Issue
Retail Shares Offered	14.21% of the Net Issue
Employee Shares Offered	0.53% of the Net Issue
Total Shares Offered	100% of the Net Issue

Entero IPO Timetable

Entero IPO will open on February 9, 2024 and close on February 13, 2024. You can join Entero IPO at 10.00 A.M. to 5.00 p.m. Upto which mandate can be applied.

Event	Date
Opening Date	9 February 2024 (Friday)
Closing Date	13 February 2024 (Tuesday)
Basis of Allotment	14 February 2024 (Wednesday)
Initiation of Refunds	15 February 2024 (Thursday)
Credit of Shares to Demat	15 February 2024 (Thursday)
Listing Date	16 February 2024 (Friday)
Deadline for UPI mandate confirmation	5 PM on 13 February 2024

Entero Healthcare Solutions IPO Lot Size

For retail investors in Entero Healthcare Solutions IPO, 11 shares will come in 1 lot or the minimum investment will be ₹13,838. Retail-individual investors can apply for up to 14 lots or the maximum investment will be ₹193,732.

Application	Lots	Shares	Amount
Retail (Min)	1	11	₹13,838
Retail (Max)	14	154	₹193,732
S-HNI (Min)	15	165	₹207,570
S-HNI (Max)	72	792	₹996,336
B-HNI (Min)	73	803	₹1,010,174

Entero Healthcare IPO Promoter Holding

The company’s promoters include Prabhat Agrawal, Prem Sethi, and OrbiMed Asia III Mauritius Limited.

Pre Issue Share Holding	77.11%
Post Issue Share Holding

Entero Healthcare Solutions Ltd IPO Key Performance Indicator ( Valuation )

In the table given below, all the figures have been told according to the latest financial year.

KPI	Values
Market Cap (₹ Cr.)	3021.21
Earning Per Share (EPS)	₹-3.10 per Equity Share
Net Asset Value (NAV)	₹157.08 per Equity Share
Post P/E Ratio (P/E) (x)	129.75
Return on Net Worth (RoNW) (%)	-1.86
Return on equity (ROE) (%)	-2.66
Return on Capital Employed (ROCE) (%)	6.06
Debt/Equity Ratio	0.45
Price/Book Value Ratio	7.22

Entero Healthcare IPO GMP Live Update, Kostak Rate day by day

Date	GMP	Kostak	Subject to
Today	₹5	–	–
10 February 2024	₹5	–	–
9 February 2024	₹10	–	–
8 February 2024	₹18	–	–

Entero Healthcare IPO Detail Video:

Entero Healthcare IPO Subscription Status (Bidding Detail)

The Entero Healthcare IPO on February 13, 2024 at 7:30:00 PM was subscribed 1.53 times, with the retail category being subscribed 1.33 times, the NII (Non-Institutional Investor) category being subscribed 0.22 times, QIB (Qualified-Institutional Buyers) category being subscribed 2.28 times and the Employee category being subscribed 1.25 times.

Category	Subscription
QIB	2.28x
NII	0.22x
Retail	1.33x
Employee	1.25x
Total	1.53x

Entero Healthcare IPO Prospectus

Entero Healthcare IPO DRHP	Download
Entero Healthcare IPO RHP	Download
Entero Healthcare IPO Anchor Investors Details PDF	Download

Entero Healthcare IPO Rating

Our Rating

1.5/5.0

Entero Healthcare Company Contact Information

Entero Healthcare Solutions Limited

Registered Office: Plot No. I-35, Building – B, Industrial Area Phase – I, 13/7 Mathura Road, Faridabad 121 003, Haryana, India
Tel: 0129-4877300
Corporate Office: 605 & 606, 6th Floor, Trade Centre Bandra Kurla Complex, Bandra East, Mumbai 400 051 Maharashtra, India
Tel: +91 22 69019100
Contact Person: Jayant Prakash, Vice President – General Counsel, Company Secretary and Compliance Officer
E-mail: jayant.prakash@enterohealthcare.com
Website: www.enterohealthcare.com
Corporate Identity Number: U74999HR2018PLC072204
Promoters of Our Company: Prabhat Agrawal, Prem Sethi, and Orbimed Asia Iii Mauritius Limited

Entero Healthcare IPO Registrar

Link Intime India Private Limited

Registered Office: C-101, 1st floor, 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West), Mumbai 400 083, Maharashtra, India
Tel: +91 8108114949
E-mail: enterohealthcare.ipo@linkintime.co.in
Investor grievance e-mail: enterohealthcare.ipo@linkintime.co.in
Website: www.linkintime.co.in
Contact person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058

Entero Healthcare IPO Lead Manager

ICICI Securities Limited

Registered Office: ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai – 400 025
Tel: +91 22 6807 7100
Email: entero.ipo@icicisecurities.com
Investor grievance email: customercare@icicisecurities.com
Website: www.icicisecurities.com
Contact person: Shekher Asnani / Gaurav Mittal
SEBI registration no: INM000011179

Dam Capital Advisors Limited

Registered Office: One BKC, Tower C, 15th Floor, Unit No. 1511, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051, Maharashtra, India
Tel: +91 22 4202 2500
E-mail: entero.ipo@damcapital.in
Investor grievance e-mail: complaint@damcapital.in
Website: www.damcapital.in
Contact Person: Arpi Chheda
SEBI Registration: MB/INM000011336

Jefferies India Private Limited

Registered Office: 16th Floor, Express Towers, Nariman Point, Mumbai 400 021, Maharashtra, India
Tel: +91 22 4356 6000
E-mail: Enterohealthcare.IPO@jefferies.com
Investor grievance e-mail: jipl.grievance@jefferies.com
Website: www. jefferies.com
Contact Person: Suhani Bhareja
SEBI Registration: INM000011443

JM Financial Limited

Registered Office: 7th Floor, Cnergy Appasaheb Marathe Marg Prabhadevi, Mumbai 400 025, Maharashtra, India
Tel: +91 22 6630 3030
E-mail: entero.ipo@jmfl.com
Investor Grievance E-Mail: grievance.ibd@jmfl.com
Website: www.jmfl.com
Contact person: Prachee Dhuri
SEBI Registration No.: INM000010361

SBI Capital Markets Limited

Registered Office: Unit No. 1501, 15th floor, A & B Wing, Parinee Crescenzo Building, Plot C- 38, G Block, Bandra Kurla Complex, Bandra (East), Mumbai- 400 051, Maharashtra.
Tel: +91 22 4006 9807
E-mail: entero.ipo@sbicaps.com
Investor Grievance E-Mail: investor.relations@sbicaps.com
Website: www.sbicaps.com
Contact person: Aditya Deshpande
SEBI Registration No.: INM000003531

Entero Healthcare IPO FAQs